Medicines · 2 min read · 22 Oct 2026
The Long Road From Venom to Prescription
Several approved peptide drugs began as molecules evolved to paralyse prey. Here is how a toxin becomes a tool.
Toxins are precision instruments
Venom peptides evolved to hit one target hard and fast: an ion channel, a receptor, a clotting enzyme. That specificity is exactly what drug developers want, minus the lethality.
A few examples
| Source | Target | Outcome |
|---|---|---|
| Cone snail | N-type calcium channel | Basis of a pain drug given into the spinal fluid |
| Pit viper | Angiotensin-converting enzyme | Led to a whole class of blood-pressure drugs |
| Gila monster venom | GLP-1 receptor | Inspired a diabetes medicine |
Each row has a named molecule behind it. The cone snail drug is ziconotide, a synthetic copy of a peptide from Conus magus, infused into the spinal fluid for severe chronic pain. The pit viper story began in 1965 with a factor in jararaca venom that strengthened bradykinin, and it ended with captopril. The lizard peptide is exendin-4, and exenatide is its synthetic form.
The conversion steps
- Isolate and sequence the active peptide from the venom mixture.
- Map the pharmacophore: which residues actually do the binding?
- Stabilise it against enzymes and kidneys with chemical edits.
- Test safety in cells and animals, then humans, in trials.
Why not just use the toxin
Natural toxins can be unstable, immunogenic or hit unrelated targets. Optimisation turns a blunt natural weapon into a narrow, dosable, manufacturable medicine. It takes years and most candidates fail.
Sources
- DailyMed, Prialt (ziconotide intrathecal infusion) label: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b025d8ed-937d-4597-9ad1-0b2f6e0ee5b1
- PubMed, PMID 14302350 (Ferreira, Br J Pharmacol 1965, bradykinin-potentiating factor in Bothrops jararaca venom): https://pubmed.ncbi.nlm.nih.gov/14302350/
- PubMed, PMID 200262 (Cushman et al., Biochemistry 1977, design of ACE inhibitors): https://pubmed.ncbi.nlm.nih.gov/200262/
- PubMed, PMID 1313797 (Eng et al., J Biol Chem 1992, exendin-4 from Heloderma suspectum venom): https://pubmed.ncbi.nlm.nih.gov/1313797/
- DailyMed, Byetta (exenatide) label: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d03c03-ebf7-418d-88a8-533eabd2ee4f
Along the table
Next element · 33 SwWhy Swallowing a Peptide Usually FailsStomach acid, enzymes and a tight intestinal wall are three separate obstacles. A pill that beats all three is a real engineering feat.
Previous element · 31 OxOxytocin and the Trouble With NicknamesIt has been called the love hormone, the cuddle chemical, the trust molecule. The lab results are far more modest and more interesting.
Same family
34Tr What a Clinical Trial Phase Actually Tells YouPhase 1, 2, 3: the numbers are everywhere in news, and most readers have no idea what question each one answers. 21Cj CJC DAC and the Weekly Dosage Question ExplainedWhat the DAC hook does to CJC 1295, what the 2006 volunteer studies measured, and why no weekly schedule has been established.